Investing Profile

Tom Woiwode

VCInvestor
Managing Director at Versant Ventures
versantventures.com/teamSan Francisco, California
Photo of Tom Woiwode, Managing Director at Versant Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Versant Ventures Managing Director
$100K - $5.0M
$1.5M
23
$102.2M
CompanyStageDateRound SizeTotal Raised
Bright Peak Therapeutics
Series CJun 2024$90M
Series BJun 2021$110M
Series AJul 2020$35M
$230M
Co-investors: Alexander Mayweg (Versant Ventures), Josh Resnick
Belharra Therapeutics
Series AJan 2023$50M
$50M
iECURE
Series ANov 2022$65M
Series ASep 2021$50M
$120M
Co-investors: Stephen Squinto (OrbiMed)
Tempest Therapeutics
Post Ipo EquityApr 2022$15M
Series BMar 2018$70M
$85M
Co-investors: Robert Weisskoff (F-Prime Capital Partners)
Vividion Therapeutics
Series CFeb 2021$140M
Series BApr 2019$82M
Series AFeb 2017$50M
$270M
Co-investors: Kristina Burow (ARCH Venture Partners), Jakob Loven (Nextech Invest)
Gritstone bio
Post Ipo EquityDec 2020$130M
Series BSep 2017$93M
Series AOct 2015$100M
$320M
Co-investors: Anthony Philippakis (GV (Google Ventures)), Peter Svennilson (The Column Group)
VectivBio
Series UnknownOct 2020$110M
Series AJan 2020$35M
$150M
Anokion
Series BSep 2019$40M
Series AMay 2014$38M
$78M
Co-investors: Florent Gros (Earlybird Venture Capital), Jack Nielsen (Vivo Capital)